We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-14.46%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.39B
AUM Growth
-$242M
Cap. Flow
+$1.44M
Cap. Flow %
0.1%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$1.44M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 55.42%
2 Consumer Staples 26.82%
3 Industrials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$687M 49.5%
8,592,007
– –
MNST icon
2
Monster Beverage
MNST
$94.3B
$372M 26.82%
9,312,976
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$142M 10.21%
690,000
– –
AXON
4
Axon Enterprise
AXON
$42.5B
$105M 7.55%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$53.8M 3.88%
34,935,485
+930,106
+3% +$1.44M
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$25.9M 1.86%
867,497
– –
SER icon
7
Serina Therapeutics
SER
$30M
$2.56M 0.18%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Broadwood Capital held 7 positions worth $1.39B, down 15% from $1.63B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 56% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q1 2022, an estimated $1.44M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.39B portfolio in Q1 2022.
  • Broadwood Capital opened 0 new positions and closed 0 in Q1 2022.
  • Broadwood Capital's portfolio value fell 15% quarter-over-quarter to $1.39B.

Based on Broadwood Capital's 13F filing for Q1 2022, filed 16 May 2022.